Publications by authors named "Charles Birbara"

Claim this Profile
E
Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis.
Alice B Gottlieb, Kim A Papp, Charles A Birbara, Catherine L Shuler, Russel Burge

J Am Acad Dermatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies.
Dafna D Gladman, Arthur Kavanaugh, Juan J Gómez-Reino, Jürgen Wollenhaupt, Maurizio Cutolo, Charles A Birbara

RMD Open· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis.
Charles Birbara, Eugene J Dabezies, Aimee M Burr, Robert J Fountaine, Michael D Smith

J Pain Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3).
Christopher J Edwards, Francisco J Blanco, Jeffrey Crowley, Charles A Birbara, Janusz Jaworski

Ann Rheum Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy.
Daniel E Furst, Arthur Kavanaugh, Stefan Florentinus, Hartmut Kupper, Mahinda Karunaratne, Charles A Birbara

Rheumatology (Oxford)· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-articular hylastan versus steroid for knee osteoarthritis.
Lawrence Housman, Nigel Arden, Thomas J Schnitzer, Charles Birbara, Thierry Conrozier

Knee Surg Sports Traumatol Arthrosc· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
Mittie K Doyle, Mahboob U Rahman, Bart Frederick, Charles A Birbara, Dick de Vries

Rheumatology (Oxford)· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tanezumab in the treatment of chronic low back pain.
Nathaniel Katz, David G Borenstein, Charles Birbara, Candace Bramson, Mary Anne Nemeth

Pain· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tanezumab for the treatment of pain from osteoarthritis of the knee.
Nancy E Lane, Thomas J Schnitzer, Charles A Birbara, Masoud Mokhtarani, David L Shelton

N Engl J Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
Jeffrey L Kaine, Alan J Kivitz, Charles Birbara, Allison Y Luo

J Rheumatol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.
Paul Emery, Mark Kosinski, Tracy Li, Marie Martin, G Rhys Williams, Charles Birbara

J Rheumatol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
Mark C Genovese, Jean-Claude Becker, Michael Schiff, Michael Luggen, Yvonne Sherrer, Charles Birbara

N Engl J Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis.
Daniel A Ollendorf, Elena Massarotti, Charles Birbara, Somali Misra Burgess

J Manag Care Pharm· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Daniel E Furst, Michael H Schiff, Roy M Fleischmann, Vibeke Strand, Charles A Birbara

J Rheumatol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
Charles A Birbara, Anthony D Puopolo, David R Munoz, Eric A Sheldon, Antoinette Mangione

J Pain· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.
Michael E Weinblatt, Edward C Keystone, Daniel E Furst, Larry W Moreland, Michael H Weisman, Charles A Birbara

Arthritis Rheum· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis